{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:25:27Z","timestamp":1782408327227,"version":"3.54.5"},"reference-count":59,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["XX"],"award-info":[{"award-number":["XX"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Access Publishing Fund of the University of Tuebingen","award":["XX"],"award-info":[{"award-number":["XX"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>(1) Background: Booster vaccinations for SARS-CoV-2 convalescents are essential for achieving herd immunity. For the first time, this study examined the influencing factors of vaccination willingness among SARS-CoV-2 infected individuals and identified vaccination-hesitant subgroups. (2) Methods: Individuals with positive SARS-CoV-2 PCR results were recruited by telephone. They completed an online questionnaire during their home isolation in Germany. This questionnaire assessed the vaccination willingness and its influencing factors. (3) Results: 224 home-isolated individuals with acute SARS-CoV-2 infection were included in the study. Vaccination willingness of home-isolated SARS-CoV-2 infected individuals with asymptomatic or moderate course was 54%. The following factors were associated with significantly lower vaccination willingness: younger age, foreign nationality, low income, low trust in vaccination effectiveness, fear of negative vaccination effects, low trust in the governmental pandemic management, low subjective informativeness about SARS-CoV-2, support of conspiracy theories. (4) Conclusions: The vaccination willingness of home-isolated SARS-CoV-2 infected individuals with asymptomatic or moderate symptomatic course was low. Motivational vaccination campaigns should be adapted to individuals with acute SARS-CoV-2 infection and consider the vaccination-hesitant groups. Vaccination education should be demand-driven, low-threshold, begin during the acute infection phase, and be guided for example by the established 5C model (\u201cconfidence, complacency, constraints, calculation, collective responsibility\u201d).<\/jats:p>","DOI":"10.3390\/vaccines10030455","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:15:04Z","timestamp":1647468904000},"page":"455","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["How to Motivate SARS-CoV-2 Convalescents to Receive a Booster Vaccination? Influence on Vaccination Willingness"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8715-578X","authenticated-orcid":false,"given":"Elias","family":"Kowalski","sequence":"first","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"Health Department Freudenstadt, 72250 Freudenstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stengel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"Charit\u00e9 Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schneider","sequence":"additional","affiliation":[{"name":"Health Department Freudenstadt, 72250 Freudenstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Goebel-Stengel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"Internal Medicine and Gastroenterology, Helios Klinik Rottweil, 78628 Rottweil, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zipfel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Graf","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2022, February 26). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201411 March 2020. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2022, March 02). COVID-19 Case Numbers. Available online: https:\/\/who.sprinklr.com\/."},{"key":"ref_3","unstructured":"Standing Committee on Vaccination at the Robert Koch Institute (2021, December 31). Epidemiologisches Bulletin 2\/2022: Beschluss der STIKO zur 16. Aktualisierung der COVID-19-Impfempfehlung. Available online: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2022\/Ausgaben\/02_22.pdf?__blob=publicationFile."},{"key":"ref_4","unstructured":"World Health Organization (WHO) (2021, December 15). WHO Issues Its First Emergency Use Validation for a COVID-19 Vaccine and Emphasizes Need for Equitable Global Access. Available online: https:\/\/www.who.int\/news\/item\/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access."},{"key":"ref_5","unstructured":"German Federal Ministry of Health (2022, March 02). Impfdashboard of the German Federal Ministry of Health, Available online: https:\/\/impfdashboard.de\/."},{"key":"ref_6","unstructured":"Robert Koch Institute (2021, December 15). Epidemiologisches Bulletin 27\/2021. COVID-19-Zielimpfquote. Available online: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2021\/Ausgaben\/27_21.pdf?__blob=publicationFile."},{"key":"ref_7","unstructured":"Robert Koch Institute (2022, March 02). COVID-19-Dashboard. Available online: https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4."},{"key":"ref_8","unstructured":"Federal Statistical Office (2022, March 02). Current Population of Germany, Available online: https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Population\/Current-Population\/_node.html;jsessionid=6C8B5377FCB640FDECE7073D34C11582.live732."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1099\/jgv.0.001439","article-title":"The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection","volume":"101","author":"Kellam","year":"2020","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"Lau","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Corman","year":"2020","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Tan","year":"2020","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","article-title":"Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection","volume":"22","author":"Zuo","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"Seow","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2827","DOI":"10.1093\/cid\/ciaa1436","article-title":"A Case of Early Reinfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"73","author":"Larson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2985","DOI":"10.1093\/cid\/ciaa1850","article-title":"Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response","volume":"73","author":"Selhorst","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","article-title":"Genomic evidence for reinfection with SARS-CoV-2: A case study","volume":"21","author":"Tillett","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2946","DOI":"10.1093\/cid\/ciaa1275","article-title":"Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing","volume":"73","author":"To","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/ciaa1330","article-title":"Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain","volume":"73","author":"Vermeersch","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(21)00675-9","article-title":"SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: A large, multicentre, prospective cohort study (SIREN)","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1002\/jmv.26982","article-title":"Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection","volume":"93","author":"Callegaro","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e151477","DOI":"10.1172\/jci.insight.151477","article-title":"Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals","volume":"6","author":"Yee","year":"2021","journal-title":"JCI Insight"},{"key":"ref_30","unstructured":"UK Health Security Agency (2022, January 24). COVID-19 Vaccination: A Guide to Booster Vaccination for Individuals Aged 18 Years and over and Those Aged 16 Years and over Who Are at Risk, Available online: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-booster-dose-resources\/covid-19-vaccination-a-guide-to-booster-vaccination-for-individuals-aged-18-years-and-over#further-information."},{"key":"ref_31","unstructured":"National Centre for Immunization and Respiratory Diseases (2022, January 24). Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States, Available online: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html#groups-recommended."},{"key":"ref_32","unstructured":"Robert Koch Institute (2021, December 16). COVID-19 Impfquoten-Monitoring in Deutschland (COVIMO)\u2014Report 8. Available online: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Projekte_RKI\/COVIMO_Reports\/covimo_studie_bericht_8.pdf?__blob=publicationFile."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1002\/jmv.27221","article-title":"Previous SARS-CoV-2 infection is linked to lower vaccination intentions","volume":"93","author":"Sprengholz","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., and B\u00f6hm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE, 13.","DOI":"10.31234\/osf.io\/ytb7w"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: Definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccines"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jocn.15951","article-title":"COVID-19 vaccination intention in the first year of the pandemic: A systematic review","volume":"31","author":"Maneze","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.puhe.2021.10.006","article-title":"Understanding and addressing vaccine hesitancy in the context of COVID-19: Development of a digital intervention","volume":"201","author":"Knight","year":"2021","journal-title":"Public Health"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lin, C., Tu, P., and Beitsch, L.M. (2020). Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines, 9.","DOI":"10.3390\/vaccines9010016"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.vaccine.2021.02.005","article-title":"International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples","volume":"39","author":"Robinson","year":"2021","journal-title":"Vaccines"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines, 9.","DOI":"10.1101\/2020.12.28.20248950"},{"key":"ref_41","first-page":"538","article-title":"Acceptance of a vaccine against COVID-19\u2014A systematic review of surveys conducted worldwide","volume":"122","author":"Snehota","year":"2021","journal-title":"Bratisl. Lek. Listy."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"106694","DOI":"10.1016\/j.ypmed.2021.106694","article-title":"Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors","volume":"150","author":"Wang","year":"2021","journal-title":"Prev. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101113","DOI":"10.1016\/j.eclinm.2021.101113","article-title":"Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review","volume":"40","author":"Cascini","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Nehal, K.R., Steendam, L.M., Campos Ponce, M., van der Hoeven, M., and Smit, G.S.A. (2021). Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis. Vaccines, 9.","DOI":"10.3390\/vaccines9101071"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Salomoni, M.G., Di Valerio, Z., Gabrielli, E., Montalti, M., Tedesco, D., Guaraldi, F., and Gori, D. (2021). Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations. Vaccines, 9.","DOI":"10.3390\/vaccines9080873"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2147\/RMHP.S311074","article-title":"The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: \u201cVaccination Refusal Could Prolong the War of This Pandemic\u201d\u2014A Systematic Review. Risk management and healthcare policy","volume":"14","author":"Wake","year":"2021","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"770985","DOI":"10.3389\/fpubh.2021.770985","article-title":"COVID-19 Vaccine Hesitancy in the United States: A Systematic Review","volume":"9","author":"Yasmin","year":"2021","journal-title":"Front. Public Health"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Fogg, B. (2009, January 26\u201329). A behavior model for persuasive design. Proceedings of the 4th International Conference on Persuasive Technology, Claremont, CA, USA.","DOI":"10.1145\/1541948.1541999"},{"key":"ref_50","first-page":"179","article-title":"The theory of planned behavior. Organizational Behavior and Human Decision","volume":"50","author":"Ajzen","year":"1991","journal-title":"Processes"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/10410236.2010.521906","article-title":"A Meta-Analysis of the Effectiveness of Health Belief Model Variables in Predicting Behavior","volume":"25","author":"Carpenter","year":"2010","journal-title":"Health Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/2372732215600716","article-title":"Using Behavioral Insights to Increase Vaccination Policy Effectiveness","volume":"2","author":"Betsch","year":"2015","journal-title":"Policy Insights Behav. Brain Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fpsyt.2021.748244","article-title":"SARS-CoV-2 Positive and Isolated at Home: Stress and Coping Depending on Psychological Burden","volume":"12","author":"Kowalski","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.2003.00546.x","article-title":"Migraine Headache Disability and Health-Related Quality-of-Life: A Population-Based Case-Control Study from England","volume":"23","author":"Lipton","year":"2003","journal-title":"Cephalalgia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","article-title":"Glycine Antagonist in Neuroprotection for Patients with Acute Stroke. GAIN Americas: A Randomized Controlled Trial","volume":"285","author":"Sacco","year":"2001","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gan, L., Chen, Y., Hu, P., Wu, D., Zhu, Y., Tan, J., Li, Y., and Zhang, D. (2021). Willingness to Receive SARS-CoV-2 Vaccination and Associated Factors among Chinese Adults: A Cross Sectional Survey. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18041993"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"The Lancet Infectious Diseases (2020). The COVID-19 infodemic. Lancet Infect. Dis., 20, 875.","DOI":"10.1016\/S1473-3099(20)30565-X"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Goebel-Stengel, M., Lohmiller, J., Sch\u00e4ffeler, N., Zipfel, S., and Stengel, A. (2022). Auswirkungen der COVID-Pandemie auf die Besorgtheit von Patient:innen mit funktionellen gastrointestinalen Symptomen. Z. Gastroenterol., 1\u201311.","DOI":"10.1055\/a-1749-6469"},{"key":"ref_59","unstructured":"Standing Committee on Vaccination at the Robert Koch Institute (2022, February 26). Epidemiologisches Bulletin 5\/2021: Beschluss der STIKO zur 2. Aktualisierung der COVID-19-Impfempfehlung. Available online: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2021\/Ausgaben\/05_21.pdf?__blob=publicationFile."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/455\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:18Z","timestamp":1760135838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vaccines10030455"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10030455","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}